Innovita Biotechnology

Innovita Biological Technology Co., Ltd., established in 2006 in Beijing, is a Chinese biotechnology company dedicated to the research, development, manufacturing, and marketing of in-vitro diagnostic tests. In 2011, the company expanded its operations by establishing a new production facility in Tangshan, Hebei province, which features five production lines for colloidal gold, real-time PCR, chemiluminescence, ELISA, and biochips. This facility spans 250 acres and includes a purification plant, with an annual production capacity of up to 20 million tests. Innovita holds ten invention patents and offers a diverse range of products that address various medical needs, including fertility, infectious diseases, sexually transmitted diseases, respiratory illnesses, drug abuse, tumor markers, and cardiac markers. The company adheres to rigorous quality standards, evidenced by certifications such as CE, ISO 13485, and GMP.